FORSØG I CENTER FOR LUNGEMEDICIN

Oversigt over åbne forsøg i Center for Lungemedicin 2017
  • A randomised, double-blind, placebo-controlled study to evaluate the safety, efficacy and changes in induced sputum and blood biomarkers following daily repeat doses of inhaled GSK2269557 for 12 weeks in adult subjects diagnosed with an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD).
  • An exploratory, randomized, double-blind, placebo-controlled study of the effects of dupilumab on airway inflammation of adults with persistent asthma.
Aktivitetsoversigt for afdelinger i Center for Lungemedicin Q1-Q4 2016

Igangværende forsøg (fyldt) og initierede forsøg (skraveret)

NEXT kontaktperson for lungemedicin

Feasibilities:

Lene Hartmann

E-mail: lhar@regionsjaelland.dk
Telefon: +45 30 57 41 50

Andre henvendelser:

Britta Smedegaard

E-mail: bsa@nextpartnership.dk

Telefon: 45+ 30 45 97 68